Malaysia’s Medical Insurance Market: Key Trends and Opportunities for 2026
An analysis of premium growth, medical inflation, and the emerging demand for specialty drug coverage in Malaysia’s insurance market — with implications for insurers, reinsurers, and distribution partners. …
Seraya One Sdn Bhd Secures Strategic Investment from MedSecure at RM 20 Million Valuation
Seraya One, Beacon’s sister entity and healthcare ecosystem aggregator, has completed a strategic investment round led by MedSecure. …
How Risk Pooling Makes Precision Medicine Affordable: Lessons From China’s 110-Million-Policy Market
China’s City-Specific Commercial Health Insurance market processed over 110 million specialty drug insurance policies in the past year. We examine the risk-pooling architecture behind this scale — and what it means for Southeast Asia. …
The Cancer Insurance Gap in Southeast Asia: Why Traditional Policies Are Failing Patients
Over 70% of cancer diagnoses across Southeast Asia occur at Stage 3 or 4 — precisely when treatment is most expensive and most effective. This analysis examines why conventional insurance products fail these patients and how Cancer Precision Medicine insurance provides a structural solution. …
Beacon Partners with Igloo to Distribute Specialty Insurance Across Five Southeast Asian Markets
Beacon has signed a referral and distribution agreement with Igloo, the leading Southeast Asian InsurTech platform, to distribute Beacon-structured insurance products across Malaysia, Indonesia, Vietnam, Thailand, and the Philippines. …
Beacon Receives Labuan Financial Services Authority Licence for Life, General and Reinsurance Broking
Beacon Global Risk Solutions Limited has been granted Licence No. BS2025152 by the Labuan Financial Services Authority, authorising the company to carry out Life Insurance, General Insurance, and Reinsurance Broking in Labuan, Malaysia. …